Abdallah Flaifel

Hemepath fellow, tweets/likes are my opinions only

[Toni Choueiri, MD @DrChoueiri]

To all pathology fellows/residents interested in a research post-doc focused on prostate cancer==> we have an open position ⁦⁦@DanaFarber_GU⁩

Please email Pr. Signoretti and Taplin:

[email protected]

[email protected] https://t.co/zhBURwDUeF

[NYUGSOM Pathology Residency @NYUGSOMpathres]

Our thoracic pathology fellow @marcelo_cassini was awarded 2nd prize by the Pulmonary Pathology Society for best posters at USCAP 2023! His “Histolopathologic analysis of donor lung at time of transplant and correlation with outcomes” took their breath away. Congrats, Marcelo!!

[NYUGSOM Pathology Residency @NYUGSOMpathres]

What better way to kick off the wellness activities of this academic year than a day trip to @StormKingArtCtr to admire large-scale sculptures under open skies? A fun day filled with art, camaraderie and relaxation #PathTwitter #pathresidents #wellness #path2path #PathMatch2023

[National Cancer Institute @theNCI]

Every person’s cancer is different. There’s no guarantee a given treatment is going to work. But a team of researchers hope to soon offer #oncologists a new tool to guide treatment choices for their patients, based on results from a small study https://t.co/N18oFLnoQI #OncTwitter

[Abdallah Flaifel @Flaifel_A]

@AminNassarMD @BrighamMedRes @YaleHemOnc Congratulations!

[National Cancer Institute @theNCI]

Mutations in cancer-related genes that start in embryos may be more common than once thought, a new study has shown.

Finding out if a person has a mosaic mutation is important for their cancer care, according to the study leaders. https://t.co/aieMBqxECv @MSKCancerCenter

[The Nobel Prize @NobelPrize]

"I'm a bit ashamed to admit this, but I was trying to hide the fact that I came from Lebanon."

2021 medicine laureate Ardem Patapoutian (@ardemp) shares his personal story of inclusion and how proud he is of his background (something that hasn't always been the case).

[NYUGSOM Pathology Residency @NYUGSOMpathres]

Reporting live from @TheUSCAP and proudly sharing more of our trainees’ presentations! Featured below: @lswang13 (PGY4), Hasanain Hasan MBChB (PGY3), and our #cytopath fellows Christine Kim MD and Fei Chen MD/PhD. Fun fact: @cf450 is also a graduate from our residency program!

[NYUGSOM Pathology Residency @NYUGSOMpathres]

As part of @TheUSCAP activities, the @nyulangone Pathology Alumni Reception is happening now! It’s so good to see so many familiar faces after a two year hiatus, cheers! 🥂 #PathTwitter #path2path #USCAP2022

[Esther Adler, MD @DrEstherAdler]

It's so nice to be back at USCAP! @nyugrossman @NYUGSOMpathres

[Abdallah Flaifel @Flaifel_A]

@anotherpathres Congrats!

[Elizabeth McKenna @ElizSMcKenna]

Now online in @CD_AACR: Characterization of INCB086550, a potent and novel small-molecule PD-L1 inhibitor @Incyte #immunotherapy https://t.co/bxxTYWXrwl

[NYUGSOM Pathology Residency @NYUGSOMpathres]

Last Sunday some of our residents and SOs went snow tubing to properly send off the winter followed by dinner at the @mountaincreek resort, all payed for by our wellness initiative! Who’s ready for spring? #residentwellness #NYUPath #path2path #PathMatch22

[NYULangonePCCSM @NYULangonePCCSM]

@nyulangone #lungtransplant and pathology teams including @Flaifel_A @FuzzFree @AndreMo77438628 describe the #pulmonary pathology of end-stage #COVID19 disease in explanted lungs and outcomes after transplant in @AJPathology

🔓 https://t.co/qsk9eaWS2h

#mededmonday

[Cancer Discovery @CD_AACR]

#OnlineFirst: Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies. https://t.co/5lwKKawyW8
@christinaleemd @SantoshVardhana @VardhanaLab @sloan_kettering #lymphoma #COVID19

[Mitch Guttman @mitchguttman]

What drives organization of RNA, DNA, and proteins in the nucleus? In our new paper out @CellCellPress, we show that non-coding RNAs play a central role through a unique RNA-based mechanism. https://t.co/X8UNGh4lKf

[Association for Molecular Pathology @AMPath]

The #AMPath21 Digital Experience Corporate Workshop Program is now live! Plan your virtual experience for the week of November 15-19 today: https://t.co/KtqYi0hlvd #molpath #pathologists

[OserLab @Oser_Lab]

Excited to share our labs newest preprint where we used CRISPR/Cas9 screening with LSD1 inhibitors to identify genes that cause LSD1 inhibitor resistance and block SCLC neuroendocrine differentiation. 1/ https://t.co/r9WOb4sjMX...

[NYUGSOM Pathology Residency @NYUGSOMpathres]

Dr. Matija Snuderl, director of Molecular Pathology Services treated the entire #molecularpath lab to celebrate the @US_FDA clearance of the NYU Langone Genome PACT (Profiling of Actionable Cancer Targets), the largest tumor NGS testing in the country with 607 exons analyzed 🧬

[syed t. hoda @01sth02]

would rather talk to a rude person
who i know is real & genuine than
a fake smile hiding indifference.